CIK 821995

JUNIPER PHARMACEUTICALS INC

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

100%

MRK · FY to 2017-12-31

Named-customer revenue

$50.0M

1 customer · FY to 2017-12-31

Latest period

Dec 31, 2017

10-K filed 2018-03-09

Thicker bands are larger estimated dollar flows. Supplier percentages are a share of the supplier's revenue; customer percentages are a share of JUNIPER PHARMACEUTICALS INC's. Dashed links are named without a figure, so their size says nothing. Click a band for its source.

How this is estimated

Dollars are the disclosed share × the discloser's revenue for that period, using the latest full year where available, or federal dollars obligated. Each side has its own scale.

Customers 1

Companies that buy from JUNIPER PHARMACEUTICALS INC, as either company disclosed it. Percentages are a share of JUNIPER PHARMACEUTICALS INC revenue. 1 active, 0 lapsed.

Company	% of JUNIPER PHARMACEUTICALS INC revenue	Est. revenue	Period	Trend	Status	Source
MRK Merck & Co., Inc.	100%	$50.0M	FY 2017-12-31	+34.0pp	Active	10-K 2018-03-09
At December 31, 2017 and 2016, Merck KGaA accounted for 100% of the product segment accounts receivable. 10-K filed 2018-03-09 Period FY 2017-01-01 to 2017-12-31 (100%)Accession 0001564590-18-005087 Merck KGaA 100 % 66 % 86 % 10-K filed 2018-03-09 Period FY 2016-01-01 to 2016-12-31 (66%), FY 2015-01-01 to 2015-12-31 (86%)Accession 0001564590-18-005087 Merck KGaA 66 % 86 % 74 % 10-K filed 2017-03-07 Period FY 2014-01-01 to 2014-12-31 (74%)Accession 0001564590-17-003520 Merck KGaA 86 % 74 % 82 % 10-K/A filed 2016-11-14 Period FY 2013-01-01 to 2013-12-31 (82%)Accession 0001193125-16-767847

Alerts are coming

Get an email when JUNIPER PHARMACEUTICALS INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.